MTOR and nasopharyngeal carcinoma: The mechanism underlying the ANRIL-dependent enhancement of NPC progression may involve the ANRIL-induced phosphorylation of Akt and thus activate the mTOR pathway, which further upregulates the expression of GLUT1 and LDHA and thus promotes NPC development [138].